CatalystFDA/Bio

InnoCare Announces Orelabrutinib in Combination with Mesutoclax Granted Breakthrough Therapy Designation in China

Breakthrough Therapy Designation in China signals regulatory

What changed

Breakthrough Therapy Designation in China signals regulatory

Why it matters

Breakthrough Therapy Designation in China signals regulatory — impact context not separately stored; see What changed.

Sources